The relationship between antithrombin administration and inflammation during veno-venous ECMO
Authors:
Open Access
- 22 August 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-9
Abstract
Veno-venous Extracorporeal Membrane Oxygenation (ECMO) is used in the most severe cases of respiratory failure and further exacerbates the patients’ inflammatory status. Antithrombin is supplemented during ECMO for its anticoagulant effects, but it also deploys anti-inflammatory properties. In this pre-specified ancillary study of the GATRA trial [NCT03208270] we aimed to evaluate the relationship between antithrombin and inflammation during ECMO. Forty-six patients were included in the study, 23 were randomized to receive antithrombin to maintain a level of 80–120% (study group) and 23 were randomized not to be supplemented (control group). Anticoagulation was provided in both groups with heparin infusion. Six cytokines were measured at 5 timepoints from prior to ECMO start to 7 days after ECMO removal. Cytokines decreased during the study but overall were not very different in the two groups. Testing the interaction between the study group and timepoints suggests that the administration of antithrombin led to a more rapid decrease over time of IL-6, IL-1β, TNF-⍺ and Pro-ADM. Plasma levels of antithrombin (either endogenous or exogenous) were negatively associated with all cytokines. Inflammation decreases during ECMO but a causal effect of antithrombin administration on the reduction of inflammation (and its clinical relevance) must be confirmed by appropriately powered studies.Keywords
This publication has 30 references indexed in Scilit:
- Effect of venovenous extracorporeal membrane oxygenation on the heart in a healthy piglet modelJournal of Cardiothoracic Surgery, 2013
- Extracorporeal Membrane Oxygenation CircuitryPediatric Critical Care Medicine, 2013
- Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokinesWorld Journal of Nephrology, 2013
- Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestineLaboratory Investigation, 2009
- THE RESPONSE OF ANTITHROMBIN III ACTIVITY AFTER SUPPLEMENTATION DECREASES IN PROPORTION TO THE SEVERITY OF SEPSIS AND LIVER DYSFUNCTIONShock, 2008
- Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatmentPerfusion, 2008
- Cytokine Imbalance in Infants Receiving Extracorporeal Membrane Oxygenation for Respiratory FailureNeonatology, 2005
- AntithrombinBlood Coagulation & Fibrinolysis, 2002
- EFFECT OF ANTITHROMBIN III SUPPLEMENTATION ON INFLAMMATORY RESPONSE IN PATIENTS WITH SEVERE SEPSISShock, 1998
- Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenationThe Journal of Pediatrics, 1996